| Year |
Citation |
Score |
| 2024 |
Randall J, Hunt AL, Nutcharoen A, Johnston L, Chouraichi S, Wang H, Winer A, Wadlow R, Huynh J, Davis J, Corgiat B, Bateman NW, Deeken JF, Petricoin EF, Conrads TP, et al. Quantitative proteomic analysis of HER2 protein expression in PDAC tumors. Clinical Proteomics. 21: 24. PMID 38509475 DOI: 10.1186/s12014-024-09476-7 |
0.59 |
|
| 2024 |
Bateman NW, Abulez T, Soltis AR, McPherson A, Choi S, Garsed DW, Pandey A, Tian C, Hood BL, Conrads KA, Teng PN, Oliver J, Gist G, Mitchell D, Litzi TJ, et al. Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities. Npj Precision Oncology. 8: 68. PMID 38480868 DOI: 10.1038/s41698-024-00519-8 |
0.551 |
|
| 2024 |
Sitler CA, Tian C, Hamilton CA, Richardson MT, Chan JK, Kapp DS, Leath CA, Casablanca Y, Washington C, Chappell NP, Klopp AH, Shriver CD, Tarney CM, Bateman NW, Conrads TP, et al. Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer-Accredited Facilities in the United States. Cancers. 16. PMID 38473428 DOI: 10.3390/cancers16051071 |
0.524 |
|
| 2024 |
Teng PN, Schaaf JP, Abulez T, Hood BL, Wilson KN, Litzi TJ, Mitchell D, Conrads KA, Hunt AL, Olowu V, Oliver J, Park FS, Edwards M, Chiang A, Wilkerson MD, ... ... Bateman NW, et al. ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic data. Iscience. 27: 109198. PMID 38439970 DOI: 10.1016/j.isci.2024.109198 |
0.533 |
|
| 2024 |
Kucera CW, Chappell NP, Tian C, Richardson MT, Tarney CM, Hamilton CA, Chan JK, Kapp DS, Leath CA, Casablanca Y, Rojas C, Sitler CA, Wenzel L, Klopp A, Jones NL, ... ... Bateman NW, et al. Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors. Gynecologic Oncology. 184: 224-235. PMID 38340648 DOI: 10.1016/j.ygyno.2024.02.005 |
0.533 |
|
| 2024 |
Winkler SS, Tian C, Casablanca Y, Bateman NW, Jokajtys S, Kucera CW, Tarney CM, Chan JK, Richardson MT, Kapp DS, Liao CI, Hamilton CA, Leath CA, Reddy M, Cote ML, et al. Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes. Gynecologic Oncology. 184: 31-42. PMID 38277919 DOI: 10.1016/j.ygyno.2024.01.009 |
0.503 |
|
| 2024 |
Hunt AL, Bateman NW, Barakat W, Makohon-Moore SC, Abulez T, Driscoll JA, Schaaf JP, Hood BL, Conrads KA, Zhou M, Calvert V, Pierobon M, Loffredo J, Wilson KN, Litzi TJ, et al. Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling. Clinical Proteomics. 21: 4. PMID 38254014 DOI: 10.1186/s12014-024-09451-2 |
0.559 |
|
| 2023 |
Buddenkotte T, Rundo L, Woitek R, Escudero Sanchez L, Beer L, Crispin-Ortuzar M, Etmann C, Mukherjee S, Bura V, McCague C, Sahin H, Pintican R, Zerunian M, Allajbeu I, Singh N, ... ... Bateman NW, et al. Deep learning-based segmentation of multisite disease in ovarian cancer. European Radiology Experimental. 7: 77. PMID 38057616 DOI: 10.1186/s41747-023-00388-z |
0.481 |
|
| 2023 |
McGee JP, Su P, Durbin KR, Hollas MAR, Bateman NW, Maxwell GL, Conrads TP, Fellers RT, Melani RD, Camarillo JM, Kafader JO, Kelleher NL. Author Correction: Automated imaging and identification of proteoforms directly from ovarian cancer tissue. Nature Communications. 14: 7946. PMID 38040721 DOI: 10.1038/s41467-023-43898-5 |
0.52 |
|
| 2023 |
Corvigno S, Badal S, Spradlin ML, Keating M, Pereira I, Stur E, Bayraktar E, Foster KI, Bateman NW, Barakat W, Darcy KM, Conrads TP, Maxwell GL, Lorenzi PL, Lutgendorf SK, et al. In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy. Npj Precision Oncology. 7: 115. PMID 37923835 DOI: 10.1038/s41698-023-00454-0 |
0.545 |
|
| 2023 |
Hunt AL, Khan I, Wu AML, Makohon-Moore SC, Hood BL, Conrads KA, Abulez T, Ogata J, Mitchell D, Gist G, Oliver J, Wei D, Chung MA, Rahman S, Bateman NW, et al. The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study. Clinical & Experimental Metastasis. PMID 37917186 DOI: 10.1007/s10585-023-10233-7 |
0.534 |
|
| 2023 |
McGee JP, Su P, Durbin KR, Hollas MAR, Bateman NW, Maxwell GL, Conrads TP, Fellers RT, Melani RD, Camarillo JM, Kafader JO, Kelleher NL. Automated imaging and identification of proteoforms directly from ovarian cancer tissue. Nature Communications. 14: 6478. PMID 37838706 DOI: 10.1038/s41467-023-42208-3 |
0.551 |
|
| 2023 |
Teng PN, Barakat W, Tran SM, Tran ZM, Bateman NW, Conrads KA, Wilson KN, Oliver J, Gist G, Hood BL, Zhou M, Maxwell GL, Leggio L, Conrads TP, Lee MR. Brain proteomic atlas of alcohol use disorder in adult males. Translational Psychiatry. 13: 318. PMID 37833300 DOI: 10.1038/s41398-023-02605-0 |
0.436 |
|
| 2023 |
Ao W, Kim HI, Tommarello D, Conrads KA, Hood BL, Litzi T, Abulez T, Teng PN, Dalgard CL, Zhang X, Wilkerson MD, Darcy KM, Tarney CM, Phippen NT, Bakkenist CJ, ... ... Bateman NW, et al. Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment. Gynecologic Oncology. 177: 60-71. PMID 37639904 DOI: 10.1016/j.ygyno.2023.08.004 |
0.546 |
|
| 2023 |
Hunt AL, Nutcharoen A, Randall J, Papazian A, Deeken J, Maxwell GL, Bateman NW, Petricoin EF, Benyounes A, Conrads TP, Cannon TL. Integration of Multi-omic Data in a Molecular Tumor Board Reveals EGFR-Associated ALK-Inhibitor Resistance in a Patient With Inflammatory Myofibroblastic Cancer. The Oncologist. PMID 37255276 DOI: 10.1093/oncolo/oyad129 |
0.509 |
|
| 2023 |
Kucera CW, Tian C, Tarney CM, Presti C, Jokajtys S, Winkler SS, Casablanca Y, Bateman NW, Mhawech-Fauceglia P, Wenzel L, Hamilton CA, Chan JK, Jones NL, Rocconi RP, O'Connor TD, et al. Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer. Jama Network Open. 6: e238437. PMID 37067801 DOI: 10.1001/jamanetworkopen.2023.8437 |
0.502 |
|
| 2023 |
Burdett NL, Willis MO, Alsop K, Hunt AL, Pandey A, Hamilton PT, Abulez T, Liu X, Hoang T, Craig S, Fereday S, Hendley J, Garsed DW, Milne K, Kalaria S, ... ... Bateman NW, et al. Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer. Nature Genetics. PMID 36849657 DOI: 10.1038/s41588-023-01320-2 |
0.555 |
|
| 2022 |
Wong KK, Bateman NW, Ng CW, Tsang YTM, Sun CS, Celestino J, Nguyen TV, Malpica A, Hillman RT, Zhang J, Futreal PA, Rojas C, Conrads KA, Hood BL, Dalgard CL, et al. Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors. Journal of Translational Medicine. 20: 606. PMID 36528667 DOI: 10.1186/s12967-022-03820-x |
0.49 |
|
| 2022 |
Garsed DW, Pandey A, Fereday S, Kennedy CJ, Takahashi K, Alsop K, Hamilton PT, Hendley J, Chiew YE, Traficante N, Provan P, Ariyaratne D, Au-Yeung G, Bateman NW, Bowes L, et al. The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer. Nature Genetics. PMID 36456881 DOI: 10.1038/s41588-022-01230-9 |
0.542 |
|
| 2022 |
Soltis AR, Bateman NW, Liu J, Nguyen T, Franks TJ, Zhang X, Dalgard CL, Viollet C, Somiari S, Yan C, Zeman K, Skinner WJ, Lee JSH, Pollard HB, Turner C, et al. Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways. Cell Reports. Medicine. 3: 100819. PMID 36384096 DOI: 10.1016/j.xcrm.2022.100819 |
0.513 |
|
| 2022 |
Handley KF, Sims TT, Bateman NW, Glassman D, Foster KI, Lee S, Yao J, Yao H, Fellman BM, Liu J, Lu Z, Conrads KA, Hood BL, Barakat W, Zhao L, et al. Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics. Jama Network Open. 5: e2236626. PMID 36239936 DOI: 10.1001/jamanetworkopen.2022.36626 |
0.577 |
|
| 2022 |
Penick ER, Bateman NW, Rojas C, Magana C, Conrads K, Zhou M, Hood BL, Wang G, Parikh N, Huang Y, Darcy KM, Casablanca Y, Mhawech-Fauceglia P, Conrads TP, Maxwell GL. Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues. Clinical Proteomics. 19: 35. PMID 36195845 DOI: 10.1186/s12014-022-09372-y |
0.565 |
|
| 2022 |
Casablanca Y, Wang G, Lankes HA, Tian C, Bateman NW, Miller CR, Chappell NP, Havrilesky LJ, Wallace AH, Ramirez NC, Miller DS, Oliver J, Mitchell D, Litzi T, Blanton BE, et al. Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study. Cancers. 14. PMID 36077609 DOI: 10.3390/cancers14174070 |
0.512 |
|
| 2022 |
Mitchell D, Hunt AL, Conrads KA, Hood BL, Makohon-Moore SC, Rojas C, Maxwell GL, Bateman NW, Conrads TP. Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment. Journal of Visualized Experiments : Jove. PMID 35723500 DOI: 10.3791/64171 |
0.485 |
|
| 2022 |
Zhu Q, Wang J, Yu H, Hu Q, Bateman NW, Long M, Rosario S, Schultz E, Dalgard CL, Wilkerson MD, Sukumar G, Huang RY, Kaur J, Lele SB, Zsiros E, et al. Whole-Genome Sequencing Identifies as a Putative Modifier of Cancer Risk in Mutation Carriers. Cancers. 14. PMID 35625955 DOI: 10.3390/cancers14102350 |
0.543 |
|
| 2022 |
Nolin AC, Tian C, Hamilton CA, Casablanca Y, Bateman NW, Chan JK, Cote ML, Shriver CD, Powell MA, Phippen NT, Conrads TP, Maxwell GL, Darcy KM. Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning. Gynecologic Oncology. PMID 35624045 DOI: 10.1016/j.ygyno.2022.05.013 |
0.447 |
|
| 2022 |
Glassman D, Bateman NW, Lee S, Zhao L, Yao J, Tan Y, Ivan C, Rangel KM, Zhang J, Conrads KA, Hood BL, Abulez T, Futreal PA, Fleming ND, Afshar-Kharghan V, et al. Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer. Cancers. 14. PMID 35326647 DOI: 10.3390/cancers14061496 |
0.58 |
|
| 2022 |
Bateman NW, Tarney CM, Abulez TS, Hood BL, Conrads KA, Zhou M, Soltis AR, Teng PN, Jackson A, Tian C, Dalgard CL, Wilkerson MD, Kessler MD, Goecker Z, Loffredo J, et al. Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry. Iscience. 25: 103665. PMID 35036865 DOI: 10.1016/j.isci.2021.103665 |
0.47 |
|
| 2021 |
Cobb LP, Siamakpour-Reihani S, Zhang D, Qin X, Owzar K, Zhou C, Conrads TP, Maxwell GL, Darcy KM, Bateman NW, Litzi T, Bae-Jump V, Secord AA. Obesity and altered angiogenic-related gene expression in endometrial cancer. Gynecologic Oncology. PMID 34538531 DOI: 10.1016/j.ygyno.2021.08.010 |
0.464 |
|
| 2021 |
Hunt AL, Bateman NW, Barakat W, Makohon-Moore S, Hood BL, Conrads KA, Zhou M, Calvert V, Pierobon M, Loffredo J, Litzi TJ, Oliver J, Mitchell D, Gist G, Rojas C, et al. Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens. Iscience. 24: 102757. PMID 34278265 DOI: 10.1016/j.isci.2021.102757 |
0.528 |
|
| 2021 |
Bateman NW, Tarney CM, Abulez T, Soltis AR, Zhou M, Conrads K, Litzi T, Oliver J, Hood B, Driggers P, Viollet C, Dalgard C, Wilkerson M, Catherino W, Hamilton CA, et al. Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients. Scientific Reports. 11: 9371. PMID 33931688 DOI: 10.1038/s41598-021-88585-x |
0.524 |
|
| 2020 |
Xuan Y, Bateman NW, Gallien S, Goetze S, Zhou Y, Navarro P, Hu M, Parikh N, Hood BL, Conrads KA, Loosse C, Kitata RB, Piersma SR, Chiasserini D, Zhu H, et al. Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studies. Nature Communications. 11: 5248. PMID 33067419 DOI: 10.1038/s41467-020-18904-9 |
0.47 |
|
| 2020 |
Lee S, Zhao L, Rojas C, Bateman NW, Yao H, Lara OD, Celestino J, Morgan MB, Nguyen TV, Conrads KA, Rangel KM, Dood RL, Hajek RA, Fawcett GL, Chu RA, et al. Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer. Cell Reports. 31: 107502. PMID 32294438 DOI: 10.1016/J.Celrep.2020.03.066 |
0.597 |
|
| 2020 |
Beer L, Sahin H, Bateman NW, Blazic I, Vargas HA, Veeraraghavan H, Kirby J, Fevrier-Sullivan B, Freymann JB, Jaffe CC, Brenton J, Miccó M, Nougaret S, Darcy KM, Maxwell GL, et al. Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis. European Radiology. PMID 32253542 DOI: 10.1007/S00330-020-06755-3 |
0.594 |
|
| 2020 |
Hunt AL, Pierobon M, Baldelli E, Oliver J, Mitchell D, Gist G, Bateman NW, Larry Maxwell G, Petricoin EF, Conrads TP. The impact of ultraviolet- and infrared-based laser microdissection technology on phosphoprotein detection in the laser microdissection-reverse phase protein array workflow. Clinical Proteomics. 17: 9. PMID 32165870 DOI: 10.1186/S12014-020-09272-Z |
0.559 |
|
| 2020 |
Rojas C, Tian C, Powell MA, Chan JK, Bateman NW, Conrads TP, Rocconi RP, Jones NL, Shriver CD, Hamilton CA, Maxwell GL, Casablanca Y, Darcy KM. Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival. Gynecologic Oncology. PMID 32029291 DOI: 10.1016/J.Ygyno.2020.01.017 |
0.475 |
|
| 2019 |
Bateman NW, Teng PN, Hope E, Hood BL, Oliver J, Ao W, Zhou M, Wang G, Tommarello D, Wilson K, Litzy T, Conrads KA, Hamilton CA, Darcy KM, Casablanca Y, et al. Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers. Cancer Medicine. PMID 31808620 DOI: 10.1002/Cam4.2729 |
0.606 |
|
| 2019 |
Tarney CM, Wang G, Bateman NW, Conrads KA, Zhou M, Hood BL, Loffredo J, Tian C, Darcy KM, Hamilton CA, Casablanca Y, Lokshin A, Conrads TP, Maxwell GL. Biomarker Panel for Early Detection of Endometrial Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. American Journal of Obstetrics and Gynecology. PMID 31279844 DOI: 10.1016/J.Ajog.2019.06.005 |
0.549 |
|
| 2019 |
Liu S, Matsuzaki J, Wei L, Tsuji T, Battaglia S, Hu Q, Cortes E, Wong L, Yan L, Long M, Miliotto A, Bateman NW, Lele SB, Chodon T, Koya RC, et al. Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer. Journal For Immunotherapy of Cancer. 7: 156. PMID 31221207 DOI: 10.1186/S40425-019-0629-6 |
0.576 |
|
| 2019 |
Kessler MD, Bateman NW, Conrads TP, Maxwell GL, Dunning Hotopp JC, O'Connor TD. Ancestral characterization of 1018 cancer cell lines highlights disparities and reveals gene expression and mutational differences. Cancer. PMID 30865299 DOI: 10.1002/Cncr.32020 |
0.548 |
|
| 2019 |
Hunt AL, Bateman NW, Wang G, Parikh N, Oliver J, Mitchell D, Gist G, Hood BL, Zhou M, Blanton B, Conrads KA, Hamilton CA, Darcy KM, Shriver CD, Casablanca Y, et al. Abstract 4709: Extensive intratumor proteogenomic heterogeneity revealed by multiregion sampling in a high-grade serous ovarian tumor specimen Cancer Research. 79: 4709-4709. DOI: 10.1158/1538-7445.Am2019-4709 |
0.434 |
|
| 2018 |
Dubil EA, Tian C, Wang G, Tarney CM, Bateman NW, Levine DA, Conrads TP, Hamilton CA, Maxwell GL, Darcy KM. Racial disparities in molecular subtypes of endometrial cancer. Gynecologic Oncology. 149: 106-116. PMID 29605044 DOI: 10.1016/J.Ygyno.2017.12.009 |
0.564 |
|
| 2018 |
Bateman NW, Conrads TP. Recent Advances and Opportunities in Proteomic Analyses of Tumor Heterogeneity. The Journal of Pathology. PMID 29344964 DOI: 10.1002/Path.5036 |
0.502 |
|
| 2018 |
Huang Y, Tarney C, Tian C, Bateman N, Conrads T, Hamilton C, Maxwell G, Darcy K. Abstract A51: Disparities in cervical cancer patients by race and histology Cancer Epidemiology, Biomarkers & Prevention. 27. DOI: 10.1158/1538-7755.Disp17-A51 |
0.602 |
|
| 2017 |
Tarney CM, Tian C, Craig ER, Crothers BA, Chan JK, Gist GD, Bateman NW, Conrads TP, Hamilton CA, Larry Maxwell G, Darcy KM. Relative Effects of Age, Race, and Stage on Mortality in Gestational Choriocarcinoma. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 29232272 DOI: 10.1097/Igc.0000000000001156 |
0.45 |
|
| 2017 |
Tarney CM, Tian C, Wang G, Dubil EA, Bateman NW, Chan JK, Elshaikh MA, Cote ML, Schildkraut JM, Shriver CD, Conrads TP, Hamilton CA, Maxwell GL, Darcy KM. Impact of age at diagnosis on racial disparities in endometrial cancer patients. Gynecologic Oncology. PMID 28800945 DOI: 10.1016/J.Ygyno.2017.07.145 |
0.519 |
|
| 2017 |
Bateman NW, Dubil EA, Wang G, Hood BL, Oliver JM, Litzi TA, Gist GD, Mitchell DA, Blanton B, Phippen NT, Tian C, Zahn CM, Cohn DE, Havrilesky LJ, Berchuck A, et al. Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients. Cancer. PMID 28654152 DOI: 10.1002/Cncr.30813 |
0.534 |
|
| 2017 |
Russo P, Hood BL, Bateman NW, Conrads TP. Quantitative Mass Spectrometry by Isotope Dilution and Multiple Reaction Monitoring (MRM). Methods in Molecular Biology (Clifton, N.J.). 1606: 313-332. PMID 28502009 DOI: 10.1007/978-1-4939-6990-6_20 |
0.435 |
|
| 2017 |
Teng PN, Bateman NW, Wang G, Litzi T, Blanton BE, Hood BL, Conrads KA, Ao W, Oliver KE, Darcy KM, McGuire WP, Paz K, Sidransky D, Hamilton CA, Maxwell GL, et al. Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line. Human Cell. PMID 28251557 DOI: 10.1007/s13577-017-0162-1 |
0.518 |
|
| 2017 |
Shoji Y, Kato-Shoji K, Conrads KA, Challa R, Hood BL, Bateman NW, Conrads TP, Risinger JI. Abstract 214: ARID1A and ARID1B dependent proteomics Cancer Research. 77: 214-214. DOI: 10.1158/1538-7445.Am2017-214 |
0.609 |
|
| 2016 |
Phippen NT, Bateman NW, Wang G, Conrads KA, Ao W, Teng PN, Litzi TA, Oliver J, Maxwell GL, Hamilton CA, Darcy KM, Conrads TP. NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer. Frontiers in Oncology. 6: 213. PMID 27833898 DOI: 10.3389/fonc.2016.00213 |
0.598 |
|
| 2016 |
Bateman NW, Byrd KA, Conrads KA, Risinger JI, Morrison C, Odunsi K, Hamilton CA, Maxwell GL, Darcy KM, Conrads TP. Abstract A19: Cytoplasmic ARID1A and poor outcome in ovarian cancer patients. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-A19 |
0.649 |
|
| 2015 |
Bateman NW, Shoji Y, Conrads KA, Stroop KD, Hamilton CA, Darcy KM, Maxwell GL, Risinger JI, Conrads TP. Identification and functional characterization of a novel bipartite nuclear localization sequence in ARID1A. Biochemical and Biophysical Research Communications. PMID 26614907 DOI: 10.1016/J.Bbrc.2015.11.080 |
0.509 |
|
| 2015 |
Bateman NW, Jaworski E, Ao W, Wang G, Litzi T, Dubil E, Marcus C, Conrads KA, Teng PN, Hood BL, Phippen NT, Vasicek LA, McGuire WP, Paz K, Sidransky D, et al. Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patients. Journal of Proteome Research. 14: 1900-10. PMID 25748058 DOI: 10.1021/Pr5012894 |
0.609 |
|
| 2015 |
Hood BL, Liu B, Alkhas A, Shoji Y, Challa R, Wang G, Ferguson S, Oliver J, Mitchell D, Bateman NW, Zahn CM, Hamilton CA, Payson M, Lessey B, Fazleabas AT, et al. Proteomics of the human endometrial glandular epithelium and stroma from the proliferative and secretory phases of the menstrual cycle. Biology of Reproduction. 92: 106. PMID 25695723 DOI: 10.1095/Biolreprod.114.127217 |
0.527 |
|
| 2015 |
Teng PN, Bateman NW, Darcy KM, Hamilton CA, Maxwell GL, Bakkenist CJ, Conrads TP. Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells. Gynecologic Oncology. 136: 554-61. PMID 25560806 DOI: 10.1016/J.Ygyno.2014.12.035 |
0.577 |
|
| 2015 |
Phippen NT, Bateman NW, Wang G, Hamilton CA, Maxwell GL, Darcy KM, Conrads TP. Abstract 4632: Poor survival associated with NUAK1 overexpression in serous ovarian cancer may be explained by chemotherapy resistance Cancer Research. 75: 4632-4632. DOI: 10.1158/1538-7445.Am2015-4632 |
0.64 |
|
| 2012 |
Barbi de Moura M, Vincent G, Fayewicz SL, Bateman NW, Hood BL, Sun M, Suhan J, Duensing S, Yin Y, Sander C, Kirkwood JM, Becker D, Conrads TP, Van Houten B, Moschos SJ. Mitochondrial respiration--an important therapeutic target in melanoma. Plos One. 7: e40690. PMID 22912665 DOI: 10.1371/Journal.Pone.0040690 |
0.49 |
|
| 2012 |
Zhao T, Zeng X, Bateman NW, Sun M, Teng PN, Bigbee WL, Dhir R, Nelson JB, Conrads TP, Hood BL. Relative quantitation of proteins in expressed prostatic secretion with a stable isotope labeled secretome standard. Journal of Proteome Research. 11: 1089-99. PMID 22077639 DOI: 10.1021/Pr200829F |
0.482 |
|
| 2011 |
Maxwell GL, Hood BL, Day R, Chandran U, Kirchner D, Kolli VS, Bateman NW, Allard J, Miller C, Sun M, Flint MS, Zahn C, Oliver J, Banerjee S, Litzi T, et al. Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation. Gynecologic Oncology. 121: 586-94. PMID 21458040 DOI: 10.1016/J.Ygyno.2011.02.031 |
0.562 |
|
| 2011 |
Bateman NW, Sun M, Bhargava R, Hood BL, Darfler MM, Kovatich AJ, Hooke JA, Krizman DB, Conrads TP. Differential proteomic analysis of late-stage and recurrent breast cancer from formalin-fixed paraffin-embedded tissues. Journal of Proteome Research. 10: 1323-32. PMID 21155598 DOI: 10.1021/pr101073s |
0.584 |
|
| 2011 |
Lu X, Beck GR, Gilbert LC, Camalier CE, Bateman NW, Hood BL, Conrads TP, Kern MJ, You S, Chen H, Nanes MS. Identification of the homeobox protein Prx1 (MHox, Prrx-1) as a regulator of osterix expression and mediator of tumor necrosis factor α action in osteoblast differentiation. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 209-19. PMID 20683885 DOI: 10.1002/Jbmr.203 |
0.442 |
|
| 2010 |
Teng PN, Bateman NW, Hood BL, Conrads TP. Advances in proximal fluid proteomics for disease biomarker discovery. Journal of Proteome Research. 9: 6091-100. PMID 21028795 DOI: 10.1021/pr100904q |
0.435 |
|
| 2010 |
Bateman NW, Sun M, Hood BL, Flint MS, Conrads TP. Defining central themes in breast cancer biology by differential proteomics: conserved regulation of cell spreading and focal adhesion kinase. Journal of Proteome Research. 9: 5311-24. PMID 20681588 DOI: 10.1021/Pr100580E |
0.537 |
|
| 2010 |
Teng PN, Rungruang BJ, Hood BL, Sun M, Flint MS, Bateman NW, Dhir R, Bhargava R, Richard SD, Edwards RP, Conrads TP. Assessment of buffer systems for harvesting proteins from tissue interstitial fluid for proteomic analysis. Journal of Proteome Research. 9: 4161-9. PMID 20518575 DOI: 10.1021/Pr100382V |
0.475 |
|
| 2009 |
Flint MS, Kim G, Hood BL, Bateman NW, Stewart NA, Conrads TP. Stress hormones mediate drug resistance to paclitaxel in human breast cancer cells through a CDK-1-dependent pathway. Psychoneuroendocrinology. 34: 1533-41. PMID 19560278 DOI: 10.1016/J.Psyneuen.2009.05.008 |
0.491 |
|
| Show low-probability matches. |